Cargando…

Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors

BACKGROUND: Cervical lymph node metastases are frequently found in papillary thyroid carcinoma (PTC) and occur in a stepwise fashion. Skip metastases that omit the central compartment and spread initially in lateral neck levels are present in a certain share of patients, and their significance is po...

Descripción completa

Detalles Bibliográficos
Autores principales: Miličić, Borna, Prstačić, Ratko, Prgomet, Drago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212598/
https://www.ncbi.nlm.nih.gov/pubmed/34219894
http://dx.doi.org/10.20471/acc.2020.59.s1.16
_version_ 1783709665771651072
author Miličić, Borna
Prstačić, Ratko
Prgomet, Drago
author_facet Miličić, Borna
Prstačić, Ratko
Prgomet, Drago
author_sort Miličić, Borna
collection PubMed
description BACKGROUND: Cervical lymph node metastases are frequently found in papillary thyroid carcinoma (PTC) and occur in a stepwise fashion. Skip metastases that omit the central compartment and spread initially in lateral neck levels are present in a certain share of patients, and their significance is poorly understood. The aim of this prospective study was to identify their possible predictors and clinicopathological factors in a group of patients with PTC with lateral lymph node (LLN) metastases. METHODS: We enrolled 68 patients with PTC with preoperatively evaluated LLN metastases who underwent total thyroidectomy with lateral lymph node dissection between 2011 and 2018. We analysed the clinicopathological features and pattern of dissemination of continuous and skip metastases. RESULTS: The prevalence of skip metastases was 23.5%. Compared with the continuous metastases group, the patients were older, had primary tumors that were more often situated unilaterally, and had smaller primary tumor size. Level II was less often involved, and none of the patients with skip metastases had all LNN positive (p = 0.05). CONCLUSION: Skip metastases occur more frequently in older patients and display certain clinicopathological features like smaller size of the primary tumor and dissemination in less lateral neck levels. In the view of the fact that they are found rather frequently, lateral neck regions should be meticulously investigated in patients with PTC without central lymph node (CLL) metastases.
format Online
Article
Text
id pubmed-8212598
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
record_format MEDLINE/PubMed
spelling pubmed-82125982021-07-01 Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors Miličić, Borna Prstačić, Ratko Prgomet, Drago Acta Clin Croat Professional Papers BACKGROUND: Cervical lymph node metastases are frequently found in papillary thyroid carcinoma (PTC) and occur in a stepwise fashion. Skip metastases that omit the central compartment and spread initially in lateral neck levels are present in a certain share of patients, and their significance is poorly understood. The aim of this prospective study was to identify their possible predictors and clinicopathological factors in a group of patients with PTC with lateral lymph node (LLN) metastases. METHODS: We enrolled 68 patients with PTC with preoperatively evaluated LLN metastases who underwent total thyroidectomy with lateral lymph node dissection between 2011 and 2018. We analysed the clinicopathological features and pattern of dissemination of continuous and skip metastases. RESULTS: The prevalence of skip metastases was 23.5%. Compared with the continuous metastases group, the patients were older, had primary tumors that were more often situated unilaterally, and had smaller primary tumor size. Level II was less often involved, and none of the patients with skip metastases had all LNN positive (p = 0.05). CONCLUSION: Skip metastases occur more frequently in older patients and display certain clinicopathological features like smaller size of the primary tumor and dissemination in less lateral neck levels. In the view of the fact that they are found rather frequently, lateral neck regions should be meticulously investigated in patients with PTC without central lymph node (CLL) metastases. Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2020-06 /pmc/articles/PMC8212598/ /pubmed/34219894 http://dx.doi.org/10.20471/acc.2020.59.s1.16 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Professional Papers
Miličić, Borna
Prstačić, Ratko
Prgomet, Drago
Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors
title Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors
title_full Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors
title_fullStr Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors
title_full_unstemmed Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors
title_short Skip Metastases in Papillary Thyroid Carcinoma – Prevalence, Predictive and Clinicopathological Factors
title_sort skip metastases in papillary thyroid carcinoma – prevalence, predictive and clinicopathological factors
topic Professional Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212598/
https://www.ncbi.nlm.nih.gov/pubmed/34219894
http://dx.doi.org/10.20471/acc.2020.59.s1.16
work_keys_str_mv AT milicicborna skipmetastasesinpapillarythyroidcarcinomaprevalencepredictiveandclinicopathologicalfactors
AT prstacicratko skipmetastasesinpapillarythyroidcarcinomaprevalencepredictiveandclinicopathologicalfactors
AT prgometdrago skipmetastasesinpapillarythyroidcarcinomaprevalencepredictiveandclinicopathologicalfactors